Innovative biometric tracking service, Forth, which helps people to navigate their way to better health using simply at-home finger-prick blood tests, has secured new investment from its first institutional investor.  The new investment came from The Development Bank of Wales, together with a group of angels from Angels Invest Wales and South West based angel investors, including Craig Gulliford, CEO of Creo Medical.

Gulliford, who was an early investor in the company during its first raise on Crowdcube in 2017 and has since joined the board, said: “I have an affinity for technology-based companies that have an innovative and disruptive proposition backed by great people. Forth ticks this box and the management team crucially also have the energy, passion, determination to succeed at all costs”.